Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Showing results for
zhenjiang mao
Your search for
Zhenfang Mao
retrieved no results
SUMOylation targeting mitophagy in cardiovascular diseases.
J Mol Med (Berl). 2022 Nov;100(11):1511-1538. doi: 10.1007/s00109-022-02258-4. Epub 2022 Sep 26.
J Mol Med (Berl). 2022.
PMID: 36163375
Review.
SUMO2-mediated SUMOylation of SH3GLB1 promotes ionizing radiation-induced hypertrophic cardiomyopathy through mitophagy activation.
Gao A, Zou J, Mao Z, Zhou H, Zeng G.
Gao A, et al. Among authors: mao z.
Eur J Pharmacol. 2022 Jun 5;924:174980. doi: 10.1016/j.ejphar.2022.174980. Epub 2022 Apr 26.
Eur J Pharmacol. 2022.
PMID: 35487252
Item in Clipboard
Corrigendum to "SUMO2-mediated SUMOylation of SH3GLB1 promotes ionizing radiation-induced hypertrophic cardiomyopathy through mitophagy activation"[Eur. J. Pharmacol. 924 (2022) 174980].
Gao A, Zou J, Mao Z, Zhou H, Zeng G.
Gao A, et al. Among authors: mao z.
Eur J Pharmacol. 2024 Apr 5;968:176456. doi: 10.1016/j.ejphar.2024.176456. Epub 2024 Feb 22.
Eur J Pharmacol. 2024.
PMID: 38395694
No abstract available.
Item in Clipboard
Cite
Cite